文献速递血液净化与透析肾移植

中欧和东欧肾脏替代治疗发病率与患病率趋势:ERA登记研究

Incidence and prevalence of kidney replacement therapy in Central and Eastern Europe-trends from the ERA Registry.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

该研究基于欧洲肾脏协会登记系统,分析19个中欧和东欧国家2010至2021年肾脏替代治疗(KRT)的发病率和患病率趋势。结果显示KRT总体发病率每年增加1.5%,患病率每年增加5.1%,但各国差异显著,且COVID-19疫情未产生重大影响。

要点

  • 中欧和东欧KRT总体发病率每年增加1.5%,各国趋势不一。
  • KRT患病率每年增加5.1%,主要归因于肾移植患病率上升。
  • COVID-19疫情未对该地区KRT发病和患病趋势产生重大影响。

核心结论

  • 中欧和东欧KRT发病率和患病率总体上升,但国家间差异远大于西欧。

研究设计与样本

  • 基于欧洲肾脏协会登记系统,纳入19个中欧和东欧国家2010至2021年 incident 和 prevalent KRT 患者数据,采用 JoinPoint 回归分析趋势。

主要发现

  • KRT发病率从2010年106.3 pmp升至2019年119.6 pmp,年均增加1.5%(95%CI +0.7至+2.6%)。
  • KRT患病率从2010年426.2 pmp升至2019年651.2 pmp,年均增加5.1%(95%CI +4.5至+5.7%)。
  • 发病率在波黑显著下降,9国稳定,8国上升;患病率除白俄罗斯稳定外所有国家均上升。
  • 患病率上升主要归因于肾移植患病率增加。
  • COVID-19疫情未对KRT发病和患病趋势产生重大影响,多数趋势持续至2021年。

临床怎么用

  • 结果有助于为中欧和东欧国家制定针对性的KRT护理优化优先事项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND HYPOTHESIS: Kidney replacement therapy (KRT) practices in Europe are heterogeneous, with apparent differences between Western and Central/Eastern Europe. However, time trends in KRT incidence and prevalence in Central and Eastern Europe have not been previously reported. Therefore, we aimed to describe trends in incidence and prevalence of KRT in Central and Eastern Europe from 2010 to 2021. METHODS: Data on incident and prevalent KRT patients from 19 Central and Eastern European countries between the years 2010 and 2021 were derived from the European Renal Association (ERA) Registry. Time trends were calculated using JoinPoint regression. RESULTS: Overall, KRT incidence increased at 1.5% [95% confidence interval (CI): +0.7 to +2.6%] per year from 106.3 per million population (pmp) in 2010 to 119.6 pmp in 2019. However, trends differed within the region. While in Bosnia and Herzegovina KRT incidence significantly decreased from 2010 to 2019, it remained stable in nine and increased in eight countries. The overall KRT prevalence increased at 5.1% (95% CI: +4.5 to +5.7%) per year from 426.2 pmp in 2010 to 651.2 pmp in 2019. KRT prevalence increased in all countries, except for Belarus where it remained stable, and was mainly attributable to increases in the prevalence of kidney transplantation. The COVID-19 pandemic did not have a major impact on KRT incidence and prevalence in the region, as most trends remained until 2021. CONCLUSIONS: Although we found an overall increase in KRT incidence and prevalence in the region, large country variations remain, much larger than observed in Western Europe. The results of this study can help to define country-specific priorities for the optimization of KRT care in Central and Eastern Europe.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Bonthuis M, Kramer A, Bakkaloğlu SA, et al. Incidence and prevalence of kidney replacement therapy in Central and Eastern Europe-trends from the ERA Registry. Nephrol Dial Transplant. 2026. PMID: 41499147. doi:10.1093/ndt/gfaf268

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。